New Experimental Drug Combination For Multiple Myeloma Available Only At NewYork-Presbyterian/Weill Cornell
Multiple myeloma, a type of blood cancer in which malignant plasma cells are overproduced in the bone marrow, has led to an estimated 20,000 new diagnoses and 11,000 deaths in 2010. Patients with the disease, who have already failed previous treatments, may be considered for a currently enrolling Phase II study, examining a unique drug combination. Myeloma begins when a plasma cell becomes …
Related posts:
- Latest Risperdal News
- Latest Zetia News
- Latest Levitra News
- Zoledronic Acid Shows Anticancer Activity In Multiple Myeloma Patients, As … – Medical News Today
- Latest Sinemet News